KLK3 and prostate carcinoma: Evans et al (15) showed in a meta-analysis that all tracers commonly used for the imaging of prostate cancer recurrence (Choline, 18F-fluciclovine and PSMA) demonstrate a similar trend of decreased detection rates at lower PSA levels.